Literature DB >> 3470774

Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it.

C S Hahn, J M Dalrymple, J H Strauss, C M Rice.   

Abstract

We have sequenced the virulent Asibi strain of yellow fever virus and compared this sequence to that of the 17D vaccine strain, which was derived from it. These two strains of viruses differ by more than 240 passages. We found that the two RNAs, 10,862 nucleotides long, differ at 68 nucleotide positions; these changes result in 32 amino acid differences. Overall, this corresponds to 0.63% nucleotide sequence divergence, and the changes are scattered throughout the genome. The overall divergence at the level of amino acid substitution is 0.94%, but these changes are not randomly distributed among the virus protein. The capsid protein is unchanged, while proteins NS1, NS3, and NS5 contain 0.5% amino acid substitutions, and proteins ns4a and ns4b average 0.8% substitutions. In contrast, proteins ns2a and ns2b have 3.0 and 2.3% amino acid divergence, respectively. The envelope protein also has a relatively high rate of amino acid change of 2.4% (a total of 12 amino acid substitutions). The large number of changes in ns2a and ns2b, which are largely conservative in nature, may result from lowered selective pressure against alteration in this region; among flaviviruses, these polypeptides are much less highly conserved than NS1, NS3, and NS5. However, many of the amino acid substitutions in the E protein are not conservative. It seems likely that at least some of the difference in virulence between the two strains of yellow fever virus results from changes in the envelope protein that affect virus binding to host receptors. Such differences in receptor binding could result in the reduced neurotropism and vicerotropism exhibited by the vaccine strain.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3470774      PMCID: PMC304575          DOI: 10.1073/pnas.84.7.2019

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Genetic analysis of the attenuation phenotype of poliovirus type 1.

Authors:  T Omata; M Kohara; S Kuge; T Komatsu; S Abe; B L Semler; A Kameda; H Itoh; M Arita; E Wimmer
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

2.  QB DNA-containing hybrid plasmids giving rise to QB phage formation in the bacterial host.

Authors:  T Taniguchi; M Palmieri; C Weissmann
Journal:  Nature       Date:  1978-07-20       Impact factor: 49.962

3.  Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein.

Authors:  J J Schlesinger; M W Brandriss; T P Monath
Journal:  Virology       Date:  1983-02       Impact factor: 3.616

4.  Cloned poliovirus complementary DNA is infectious in mammalian cells.

Authors:  V R Racaniello; D Baltimore
Journal:  Science       Date:  1981-11-20       Impact factor: 47.728

5.  Complete nucleotide sequence of the genomic RNA of Sindbis virus.

Authors:  E G Strauss; C M Rice; J H Strauss
Journal:  Virology       Date:  1984-02       Impact factor: 3.616

6.  Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution.

Authors:  C M Rice; E M Lenches; S R Eddy; S J Shin; R L Sheets; J H Strauss
Journal:  Science       Date:  1985-08-23       Impact factor: 47.728

Review 7.  Rapid evolution of RNA genomes.

Authors:  J Holland; K Spindler; F Horodyski; E Grabau; S Nichol; S VandePol
Journal:  Science       Date:  1982-03-26       Impact factor: 47.728

8.  Nucleotide sequence heterogeneity of an RNA phage population.

Authors:  E Domingo; D Sabo; T Taniguchi; C Weissmann
Journal:  Cell       Date:  1978-04       Impact factor: 41.582

9.  Direct method for quantitation of extreme polymerase error frequencies at selected single base sites in viral RNA.

Authors:  D A Steinhauer; J J Holland
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

10.  Ontogeny of yellow fever 17D vaccine: RNA oligonucleotide fingerprint and monoclonal antibody analyses of vaccines produced world-wide.

Authors:  T P Monath; R M Kinney; J J Schlesinger; M W Brandriss; P Brès
Journal:  J Gen Virol       Date:  1983-03       Impact factor: 3.891

View more
  75 in total

1.  Phylogenetic and evolutionary relationships among yellow fever virus isolates in Africa.

Authors:  J P Mutebi; H Wang; L Li; J E Bryant; A D Barrett
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  High fidelity of yellow fever virus RNA polymerase.

Authors:  Konstantin V Pugachev; Farshad Guirakhoo; Simeon W Ocran; Fred Mitchell; Megan Parsons; Caroline Penal; Soheila Girakhoo; Svetlana O Pougatcheva; Juan Arroyo; Dennis W Trent; Thomas P Monath
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

3.  Molecular characterization of a hamster viscerotropic strain of yellow fever virus.

Authors:  Monica A McArthur; Miguel T Suderman; John-Paul Mutebi; Shu-Yuan Xiao; Alan D T Barrett
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

4.  Identification of envelope protein epitopes that are important in the attenuation process of wild-type yellow fever virus.

Authors:  B K Sil; L M Dunster; T N Ledger; M R Wills; P D Minor; A D Barrett
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

5.  Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3.

Authors:  S Butrapet; C Y Huang; D J Pierro; N Bhamarapravati; D J Gubler; R M Kinney
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine.

Authors:  C Y Huang; S Butrapet; D J Pierro; G J Chang; A R Hunt; N Bhamarapravati; D J Gubler; R M Kinney
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

7.  Presence of poly(A) in a flavivirus: significant differences between the 3' noncoding regions of the genomic RNAs of tick-borne encephalitis virus strains.

Authors:  C W Mandl; C Kunz; F X Heinz
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

8.  The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization.

Authors:  F X Heinz; C W Mandl; H Holzmann; C Kunz; B A Harris; F Rey; S C Harrison
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

9.  Homogeneity of yellow fever virus strains isolated during an epidemic and a post-epidemic period in West Africa.

Authors:  M R Pisano; J Nicoli; H Tolou
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

10.  Neuroadapted yellow fever virus 17D: genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular clone.

Authors:  T J Chambers; M Nickells
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.